2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
Рекомендации ACC/AHA/ACCP/HRS 2023 года по диагностике и лечению фибрилляции предсердий: доклад Объединённого комитета Американского колледжа кардиологии и Американской кардиологической ассоциации по рекомендациям в области клинической практики
2023-11-30
SCID: 54.1/enuxjedf
Discuss with AI
anticoagulationatrial fibrillationcatheter ablationleft atrial appendage occlusionthromboembolic risk assessment
Figures from the paper
Abstract (AI)
AIM: The "2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation" provides recommendations to guide clinicians in the treatment of patients with atrial fibrillation. METHODS: A comprehensive literature search was conducted from May 12, 2022, to November 3, 2022, encompassing studies, reviews, and other evidence conducted on human subjects that were published in English from PubMed, EMBASE, the Cochrane Library, the Agency for Healthcare Research and Quality, and other selected databases relevant to this guideline. Additional relevant studies, published through November 2022, during the guideline writing process, were also considered by the writing committee and added to the evidence tables, where appropriate. STRUCTURE: Atrial fibrillation is the most sustained common arrhythmia, and its incidence and prevalence are increasing in the United States and globally. Recommendations from the "2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation" and the "2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation" have been updated with new evidence to guide clinicians. In addition, new recommendations addressing atrial fibrillation and thromboembolic risk assessment, anticoagulation, left atrial appendage occlusion, atrial fibrillation catheter or surgical ablation, and risk factor modification and atrial fibrillation prevention have been developed.
Key Findings
1
It provides clinical recommendations for diagnosing and treating atrial fibrillation, whose incidence and prevalence are increasing globally and in the United States.
2
New recommendations address thromboembolic risk assessment and anticoagulation in patients with atrial fibrillation.
3
Risk-factor modification and atrial fibrillation prevention are newly addressed as components of comprehensive management.
4
The 2023 guideline updates the 2014 atrial fibrillation management recommendations and incorporates evidence published through November 2022.
5
The guideline adds recommendations on left atrial appendage occlusion and catheter or surgical atrial fibrillation ablation.
Research Object
Atrial fibrillation
Research Subject
Diagnosis, treatment, management, thromboembolic risk assessment, anticoagulation, left atrial appendage occlusion, ablation, and risk-factor modification for atrial fibrillation
Publication Details
Publication Date
2023-11-30
Journal
Publisher
ISSN
Cited by
3302
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest
References available in scid.ai7
2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)2020
Heart Disease and Stroke Statistics—2023 Update: A Report From the American Heart Association2023
2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association2021
2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy2018
Calcium Signaling and Cardiac Arrhythmias2017
Oral anticoagulants for prevention of stroke in atrial fibrillation: systematic review, network meta-analysis, and cost effectiveness analysis2017
Call to Action: Rural Health: A Presidential Advisory From the American Heart Association and American Stroke Association2020
Cited by2
2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines2025
2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines2025